| Age, yrs, median (IQR) |
59 [47, 70] |
58 [45, 67] |
56 [43, 65] |
0.063 |
| Male sex, % |
46.83 |
52.20 |
36.22 |
0.024 |
| ASA class ≥ 3, % |
61.26 |
62.18 |
68.25 |
0.328 |
| Mallampati score 4, % |
0.44 |
0.65 |
1.67 |
0.289 |
| Procedural data |
|
|
|
|
| Endoscopy time (min), median (IQR) |
25 [15, 40] |
23 [15, 37] |
26 [15, 39] |
0.752 |
| Position, prone, % |
49.48 |
44.68 |
40.71 |
0.166 |
| No response to endoscopic intubation, % |
90.73 |
84.18 |
85.04 |
0.018 |
| Aldrete score in recovery, median (IQR) |
9 [8, 9] |
9 [8, 10] |
9 [8, 10] |
0.004 |
| Pharmacologic data |
|
|
|
|
| Combination propofol for induction, % |
53.56 |
66.67 |
55.91 |
0.011 |
| Induction propofol dose (mg/kg), median (IQR) |
1.81 [1.15, 3.15] |
1.35 [0.91, 2.22] |
1.28 [0.87, 2.19] |
<.001 |
| Total propofol dose (mg/kg/min), median (IQR) |
0.21 [0.14, 0.31] |
0.16 [0.11, 0.21] |
0.17 [0.11, 0.23] |
<.001 |
| Propofol infusion time (min), median (IQR) |
30 [20, 44] |
30 [20, 39] |
31 [20, 46] |
0.595 |
